Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Nutraceutical Market
Nutraceutical Market size was worth more than USD 423 billion in 2022 and is poised to grow significantly at over 4.5% CAGR from 2023 to 2032 owing to the high prevalence of metabolic disorders worldwide.
Nutraceuticals help in the treatment of the underlying causes of metabolic disorders and their associated complications while positively influencing various biochemical and clinical outcomes. As a result, nutraceuticals, including multivitamins, have grown increasingly important as vital components of consumer lifestyles. According to the International Diabetes Federation and the National Cholesterol Education Program, the prevalence of metabolic syndromes exceeded 30% in the U.S. Consequently, the increasing usage of nutraceuticals to provide health and wellness advantages will promote the market expansion.
The presence of stringent and complex regulatory structures for the commercialization of nutraceutical products may hinder the market growth. Nutraceutical products are regulated by different authorities in multiple countries to ensure product safety and quality. Additionally, strict guidelines have been laid down for supporting the health claims. The time-consuming procedures for product assessment and approvals is also a major factor limiting the market expansion
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Nutraceutical Market Size in 2022: | USD 423 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 4.7% |
2032 Value Projection: | USD 684 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 270 |
Tables, Charts & Figures: | 503 |
Segments covered: | Product, Form, Condition, Distribution Channel and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|